Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 85%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,341
Total Claims
$2.3M
Drug Cost
396
Beneficiaries
$5,833
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+23%
Opioid rate vs peers
7.7% vs 6.3% avg
-57%
Cost per patient vs peers
$5,833 vs $14K avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.7%
Opioid Rate
181
Opioid Claims
$12K
Opioid Cost
9.9%
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 2,029 claims · $317K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Palbociclib | 40 | $607K |
| Elacestrant Hcl | 13 | $310K |
| Everolimus | 27 | $158K |
| Peginterferon Alfa-2a | 12 | $55K |
| Rivaroxaban | 58 | $43K |
| Venetoclax | 16 | $35K |
| Lipase/Protease/Amylase | 13 | $21K |
| Exemestane | 64 | $15K |
| Apixaban | 21 | $13K |
| Imatinib Mesylate | 16 | $11K |
| Tamoxifen Citrate | 225 | $7,412 |
| Abiraterone Acetate | 14 | $6,210 |
| Anastrozole | 244 | $5,317 |
| Edoxaban Tosylate | 12 | $5,238 |
| Enoxaparin Sodium | 13 | $3,748 |
Prescribing Profile
Patient Profile
74
Avg Age
80%
Female
2.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About